CREB3L3 and osteoporosis: Inhibition of ER stress, however, reduced the expression of osteoclast-related genes and CREB3L3 activation, and thereby prevented RANKL-induced bone destruction, suggesting the inactivation of ER stress CREB3L3-induced signaling pathways may be of therapeutic use for the treatment of osteoporosis [51].